Therapeutic Antibodies – News and Features
News
Dyax and ZymoGenetics Enter Into Library License Agreement
Companies announce agreement for discovery of therapeutic antibodies.
News
Researchers Describe Gene’s Role in Breast Cancer
Analysis of breast-cancer gene role offers promising target for drugs to stop or slow progression of the disease.
News
CAT and MSM Enter Drug Discovery Collaboration
Collaboration aimed at developing antibody-based drugs targeting multi-spanning membrane proteins.
News
Morphotek Raises $40 Million to Advance Its Antibody Pipeline
The funds will be used primarily to further clinical development of the Company's lead therapeutic antibodies.
News
Lumera Signs Agreement with Institute for Systems Biology to Address Cancer Detection
Extended partnership to focus on developing methods with the ProteomicProcessor™ for cancer biomarker detection.
News
Pepscan Secures Euro 7 Million in its Second Financing Round
Company also launches its phase I/II GNRH vaccine trial for the treatment of hormone dependant prostate cancer.
News
Lumera Scientist Previews Company's Therapeutic Antibody Drug Discovery Products
The presentation detailed the analysis of a high density antibody microarray for potential drug discovery "hits" to the cancer antigen.
News
Research and Markets Announces the Addition of Monoclonal Antibody Based Products - Global Strategic Business Report
Monoclonal antibody-based therapeutics for cancer are featured inside global strategic business report on monoclonal antibody based products.
News
Affitech to Play key Role in Major EU Embryonal Tumor Pipeline Project
Proprietary discovery platforms to be utilized to identify fully human therapeutic antibody candidates.
News
NIH Selects Regeneron for Knockout Mouse Project
Regeneron will use its VelociGene® technology to target 3,500 genes over five years, providing models of human diseases.
Advertisement
